Fisher Patrick sold $1K of OFIX
Fisher Patrick (President, Global Limb Recon) sold 150 shares of Orthofix Medical Inc. (OFIX) at $9.44 on 2026-10-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
A modest insider sell typically has limited price effect, but traders may watch for any follow‑on activity.
Market read
The filing is a routine insider sale with low material impact; relevance is primarily for compliance monitoring.
What to watch
Insider retains a large position (over 50,000 shares) and the sale was pre‑arranged, reducing informational value.
Background
SEC Form 4 filings provide the first public disclosure of insider transactions.
Ticker impact
Form 4 disclosed President Fisher Patrick sold 150 shares for $1,416 via a 10b5‑1 plan.
potential slight downward pressure as market prices the insider sell
The transaction size is modest ($1.4k) and represents a routine 10b5‑1 sale; impact is limited but could cause minor short‑term pressure.
Market effects
Minimal; Orthofix operates in medical devices, a single insider sale does not affect the sector.
None; the filing is company‑specific.
Low; no broader market impact.
Counterpoint
The sale could be a routine liquidity move and not indicative of any negative outlook.
Key entities
- CompanyOrthofix Medical Inc.
Medical device manufacturer listed on Nasdaq (OFIX).
- InsiderFisher Patrick
President, Global Limb Recon at Orthofix.